Literature DB >> 28901677

Natriuretic peptides in the control of lipid metabolism and insulin sensitivity.

K Verboven1,2, D Hansen2,3, J W E Jocken1, E E Blaak1.   

Abstract

Natriuretic peptides have long been known for their cardiovascular function. However, a growing body of evidence emphasizes the role of natriuretic peptides in human substrate and energy metabolism, thereby connecting the heart with several insulin-sensitive organs like adipose tissue, skeletal muscle and liver. Obesity may be associated with an impaired regulation of the natriuretic peptide system, also indicated as a natriuretic handicap. Evidence points towards a contribution of this natriuretic handicap to the development of obesity, type 2 diabetes mellitus and cardiometabolic complications, although the causal relationship is not fully understood. Nevertheless, targeting the natriuretic peptide pathway may improve metabolic health in obesity and type 2 diabetes mellitus. This review will focus on current literature regarding the metabolic roles of natriuretic peptides with emphasis on lipid metabolism and insulin sensitivity. Furthermore, it will be discussed how exercise and lifestyle intervention may modulate the natriuretic peptide-related metabolic effects.
© 2017 World Obesity Federation.

Entities:  

Keywords:  Insulin resistance; lipid metabolism; natriuretic peptides

Mesh:

Substances:

Year:  2017        PMID: 28901677     DOI: 10.1111/obr.12598

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  12 in total

1.  Inhibition of phosphodiesterase type 9 reduces obesity and cardiometabolic syndrome in mice.

Authors:  Sumita Mishra; Nandhini Sadagopan; Brittany Dunkerly-Eyring; Susana Rodriguez; Dylan C Sarver; Ryan P Ceddia; Sean A Murphy; Hildur Knutsdottir; Vivek P Jani; Deepthi Ashok; Christian U Oeing; Brian O'Rourke; Jon A Gangoiti; Dorothy D Sears; G William Wong; Sheila Collins; David A Kass
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

2.  Effects of sacubitril/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials.

Authors:  Magnus O Wijkman; Brian Claggett; Muthiah Vaduganathan; Jonathan W Cunningham; Rasmus Rørth; Alice Jackson; Milton Packer; Michael Zile; Jean Rouleau; Karl Swedberg; Martin Lefkowitz; Sanjiv J Shah; Marc A Pfeffer; John J V McMurray; Scott D Solomon
Journal:  Cardiovasc Diabetol       Date:  2022-06-18       Impact factor: 8.949

Review 3.  Angiotensin receptor neprilysin inhibitor as a novel antihypertensive drug: Evidence from Asia and around the globe.

Authors:  Donna S-H Lin; Tzung-Dau Wang; Peera Buranakitjaroen; Chen-Huan Chen; Hao-Min Cheng; Yook Chin Chia; Apichard Sukonthasarn; Jam Chin Tay; Boon Wee Teo; Yuda Turana; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-11       Impact factor: 3.738

4.  Cardiovascular, anthropometric, metabolic and hormonal profiling of normotensive women with polycystic ovary syndrome with and without biochemical hyperandrogenism.

Authors:  Małgorzata Kałużna; Tomasz Krauze; Katarzyna Ziemnicka; Katarzyna Wachowiak-Ochmańska; Jolanta Kaczmarek; Adam Janicki; Andrzej Wykrętowicz; Marek Ruchała; Przemysław Guzik
Journal:  Endocrine       Date:  2021-02-22       Impact factor: 3.633

Review 5.  Atrial Natriuretic Peptide31-67: A Novel Therapeutic Factor for Cardiovascular Diseases.

Authors:  Gustavo Jose Justo da Silva; Raffaele Altara; George W Booz; Alessandro Cataliotti
Journal:  Front Physiol       Date:  2021-07-08       Impact factor: 4.566

6.  β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.

Authors:  Sabine Tauscher; Hitoshi Nakagawa; Katharina Völker; Franziska Werner; Lisa Krebes; Tamara Potapenko; Sören Doose; Andreas L Birkenfeld; Hideo A Baba; Michaela Kuhn
Journal:  Cardiovasc Diabetol       Date:  2018-07-17       Impact factor: 9.951

7.  A novel peptide RIFV suppresses human adipocyte differentiation through the inhibition of C/EBP-β expression.

Authors:  Wen Zhang; Dan Shen; Yun Li; Hong Zhong; Xing Wang; Xian-Wei Cui; Chun-Mei Shi; Chen-Bo Ji; Xi-Rong Guo; Ling Chen
Journal:  Nutr Metab (Lond)       Date:  2019-12-23       Impact factor: 4.169

Review 8.  Adipokines, Myokines, and Cardiokines: The Role of Nutritional Interventions.

Authors:  Pamela Senesi; Livio Luzi; Ileana Terruzzi
Journal:  Int J Mol Sci       Date:  2020-11-08       Impact factor: 5.923

9.  Cardiac‑specific deletion of natriuretic peptide receptor A induces differential myocardial expression of circular RNA and mRNA molecules involved in metabolism in mice.

Authors:  Baoying Chen; Pan Chang; Xi Shen; Xiaomeng Zhang; Jing Zhang; Xihui Wang; Jun Yu
Journal:  Mol Med Rep       Date:  2020-11-17       Impact factor: 2.952

10.  Association Between Serum Furin and Fasting Glucose: A Cross-Sectional Study in Chinese Adults.

Authors:  Yan He; Hanyun Zhu; Min Zhang; Jing Li; Shengqi Ma; Yin Lu; Linan Chen; Mingzhi Zhang; Hao Peng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-03       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.